New patent for Gilead Sciences drug VEKLURY

Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eleven…
The post New patent for Gilead Sciences drug VEKLURY appeared first on DrugPat…


Drug Patent Expirations for the Week of December 4, 2022

VIIBRYD (vilazodone hydrochloride) Allergan Patent: 8,673,921 Expiration: Dec 5, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post D…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog